HCA Related Analyst Ratings
-
IPPS Rule Proposal a Positive for Hospital Stocks - Jefferies (CYH) (HMA) (HCA) (THC)
-
Deutsche Bank Cuts Community Health (CYH), Health Management (HMA) and Tenet (THC) to Hold
-
Morgan Stanley Starts HCA Holdings (HCA) at Overweight
-
Imperial Capital Says HCA Holdings (HCA) Looking More Like Growth Stock
-
Cantor Fitzgerald's Conviction Calls For 2013
-
JPMorgan Starts HCA Holdings (HCA) at Overweight
-
Goldman Sachs Upgrades HCA Holdings (HCA) to Buy
-
Barclays Starts HCA Holdings (HCA) at Overweight
-
Imperial Capital Starts HCA Holdings (HCA) at Outperform
-
Despite Negative New York Times Article "Dubius Cardiac", Jefferies Maintains Buy on HCA Inc (HCA)
-
Raymond James Downgrades HCA Holdings (HCA) to Outperform
-
Canaccord Genuity Morning Coffee on SPDR Health Care E.T.F. (XLV): Good News, Bad News
-
UPDATE - UBS initiates coverage on HCA (HCA) with a Buy; Uncanny Ability to Opportunistically Create Value
-
UBS Starts CYH, HMA, HCA at Buy, THC, CCRN, VHS, UHS, LPNT at Neutral
-
Citi Upgrades Healthcare Stocks Ahead of Supreme Court Decision on Reform (THC) (HMA) (CYH) (HCA) (UHS) (VHS) (LPNT)
-
Cantor Fitzgerald Starts HCA Holdings (HCA) at Buy; A Room Full of Possibilities
-
Avondale Partners Starts HCA Holdings (HCA) at Market Outperform
-
Deutsche Bank Upgrades HCA Holdings (HCA) to Buy; Shift In Stance
-
Jefferies Lifts Numbers on HCA (HCA), Could Be Seeing Early Stages of a Recovery
-
UBS Maintains a 'Buy' on HCA Holdings (HCA); Solid Quarter, Guidance In-line
-
Auriga Reiterates a 'Hold' on HCA Holdings (HCA); Monster Beat, Guidance Solid, But Headline Risks Still Exist
-
Goldman Sachs Raises Price Target on HCA (HCA) Following Q4, Maintains Neutral Rating
-
UPDATE - Auriga Downgraded HCA Holdings (HCA) to Hold; Macro Issues Moderate, But Still Present Over Next 12 Months
-
Auriga Downgrades HCA Holdings (HCA) to Hold
-
Citi Downgrades HCA Holdings (HCA) to Neutral
-
Barclays on Health Care Facilities: Thoughts on the Expansion of Managed Medicaid in Texas and Preservation of the Upper Payment Limit Program
-
Barclays on Health Care Facilities: Headline Risk Around Florida Medicaid Is Not a Surprise
-
Raymond James Upgrades HCA Holdings (HCA) to Strong Buy
-
BMO Capital Starts HCA Holdings (HCA) at Market Perform
-
Barclays Maintains an 'Overweight' on HCA Holdings (HCA); Thoughts on Accounting Change for HITECH Revenue
-
Barclays on Medical Supplies & Devices: 3Q Preview: No Bounce Back in Sight
-
Deutsche Bank Downgrades HCA Holdings (HCA) to Hold; Headwinds Appear Too Strong
-
Barclays Maintains an 'Overweight' on HCA Holdings (HCA); Thoughts on Barron's Article on HCA's Accounting Policies
-
Barclays Maintains an 'Overweight' on HCA Holdings (HCA); Upside Potential Outweighs the Risk
-
Barclays Maintains an 'Overweight' on HCA Holdings (HCA); Comments on Supplemental Disclosures from June Qtr
-
Cowen Downgrades HCA Holdings (HCA) to Neutral
-
Auriga Starts HCA Holdings (HCA) at Buy; Concern Over Decline in Medicare Acuity in 2Q Appears Overdone
-
Barclays Maintains an 'Overweight' on HCA Holdings (HCA); June Quarter Review: After the Call
-
UBS Maintains a 'Buy' on HCA Holdings (HCA); Tough Start Out of the Gate Post IPO
-
Goldman Sachs Downgrades HCA Holdings (HCA) to Neutral
-
Jefferies Upgrades HCA Holdings (HCA) to Buy
-
Barclays maintains an 'Overweight' on HCA Holdings (HCA); HealthOne Transaction Should Provide a Healthy Boost to EPS
-
Barclays on Medical Supplies & Devices: 1Q Hospital Takeaways for MedTech Investors
-
Barclays Maintains an 'Overweight' on HCA Holdings (HCA); March Quarter 10-Q Review
-
CRT Capital Starts HCA Holdings (HCA) at Buy
-
UPDATE - Barclays Initiates Coverage on HCA Holdings (HCA) with an Overweight; Return of the Real Tennessee Titans
-
Raymond James Starts HCA Holdings (HCA) at Outperform
-
Deutsche Bank Starts HCA Holdings (HCA) at Buy: PT $41
-
Caris & Co. Starts HCA Holdings (HCA) at Above Average
-
BofA/Merrill Lynch Starts HCA Holdings (HCA) at Buy
Back to HCA Stock Lookup
